Skip to main content
PMC home page
Springer logoLink to Springer
. 2018 Jan 5;445(1):187–194. doi: 10.1007/s11010-017-3264-x

Decreased coronary arteriolar response to KCa channel opener after cardioplegic arrest in diabetic patients

Yuhong Liu 1, Victoria Cole 1, Isabella Lawandy 1, Afshin Ehsan 1, Frank W Sellke 1, Jun Feng 1,2,✉
PMCID: PMC6033646  NIHMSID: NIHMS953725  PMID: 29305679

Abstract

We have recently found that diabetes is associated with the inactivation of the calcium-activated potassium channels (KCa) in endothelial cells, which may contribute to endothelial dysfunction in diabetic patients at baseline. In the current study, we further investigated the effects of diabetes on coronary arteriolar responses to the small (SK) and intermediate (IK) KCa opener NS309 in diabetic and non-diabetic patients and correlated that data with the changes in the SK/IK protein expression/distribution in the setting of cardioplegic ischemia and reperfusion (CP) and cardiopulmonary bypass (CPB). Coronary arterioles from the harvested right atrial tissue samples from diabetic and non-diabetic patients (n = 8/group) undergoing cardiac surgery were dissected pre- and post-CP/CPB. The in vitro relaxation response of pre-contracted arterioles was examined in the presence of the selective SK/IK opener NS309 (10−9–10−5 M). The protein expression/localization of KCa channels in the harvested atrial tissue samples, coronary microvessels, and primary cultured human coronary endothelial cells were assayed by Western blotting and immunohistochemistry. The relaxation response to NS309 post-CP/CPB was significantly decreased in diabetic and non-diabetic groups compared to their pre-CP/CPB responses, respectively (P < 0.05). Furthermore, this decrease was greater in the diabetic group than that of the non-diabetic group (P < 0.05). There were no significant differences in the total protein expression/distribution of SK/IK in the human myocardium, coronary microvessels or coronary endothelial cells between diabetic and non-diabetic groups or between pre- and post-CP/CPB (P > 0.05). Our results suggest that diabetes further inactivates SK/IK channels of coronary microvasculature early after CP/CPB and cardiac surgery. The lack of diabetic changes in SK/IK protein abundances in the setting of CP/CPB suggests that the effect is post-translational. This alteration may contribute to post-operative endothelial dysfunction in the diabetic patients early after CP/CPB and cardiac surgery.

Keywords: Calcium-activated potassium channels, Cardioplegia, Cardiopulmonary bypass, Diabetes, Coronary microcirculation, Endothelial-dependent hyperpolarizing factor

Introduction

Cardioplegic arrest (CP) in the setting of cardiopulmonary bypass (CPB) is often associated with decreased coronary arteriolar endothelial and vasomotor function [1–10]. In particular, these disturbances are more profound in diabetic patients [10–16]. The mechanisms responsible for CP/CPB-induced coronary and peripheral microvascular dysfunction have been extensively studied by our groups and others [1–5]. We have found that dys-regulation of electrical signaling in the coronary endothelial cells plays a key role in endothelial dysfunction in patients after cardiac surgery. This electrical signaling is mediated by small (SK) and intermediate (IK) conductance calcium-activated-potassium channels (KCa), which are largely responsible for coronary arteriolar relaxation mediated by endothelium-dependent hyperpolarizing factors (EDHF) [17, 20]. We have demonstrated that inactivation of the endothelial SK/IK channels contributes to CP/CPB-induced microvascular endothelial dysfunction early after cardiac surgery [17–19]. Of significance, we found that diabetes is also associated with the inactivation of SK/IK channels, which may contribute to coronary endothelial dysfunction in the diabetic patients at baseline  [20]. Therefore, we hypothesized that diabetes may further cause down-regulation of SK/IK in the setting of CP/CPB and cardiac surgery. In the current study, we investigated the effects of diabetes on coronary arteriolar responses to the selective SK/IK opener NS309 in diabetic and non-diabetic patients and correlated these effects with the changes in the SK/IK protein expression/distribution in the setting of CP/CPB and cardiac surgery.

Methods

Human subjects and tissue harvesting

Right atrial tissue samples were harvested from patients undergoing cardiac surgery before (pre-CP/CPB) and after (post-CP/CPB) exposure of the heart to CP and CPB [7, 8, 13, 14, 17]. Harvested tissue samples were immediately frozen in liquid nitrogen (immunoblotting), fixed in 10% formalin for 24 h followed by paraffinization and sectioning into 5-µm slices (immunofluorescent staining), or placed in cold (5–10 °C) Krebs-Henseleit buffer (microvascular studies) [20]. All procedures were approved by the Institutional Review Board (IRB) of Rhode Island Hospital, Alpert Medical School of Brown University, and informed consent was obtained from all enrolled patients. The patients were then divided into the following two groups: (1) non-diabetic patients (ND) with a normal hemoglobin A1c (HgbA1c) and no history or treatment for diabetes; (2) diabetic patients (DM) with a HgbA1c ≥ 8.5 [13, 14].

Microvessel reactivity

Coronary microvessels (80–150 µm internal diameters, n = 8/group) were dissected from harvested atrial tissue samples taken pre- and post-CPB. Microvessel studies were performed in vitro in a pressurized (40 mmHg) no-flow state using video-microscopy as previously described [17–20]. The vessel was pre-contracted with endothelin-1 (10−8–10−7 M) to achieve 30–40% of baseline diameter. The selective SK/IK inhibitor NS309 (10−9–5 × 10−5 M) was added to the organ bath and diameter measurements were taken. We have determined previously that the response of human coronary arterioles to NS309 is endothelium dependent [17, 18, 20].

Immunoblot

The methods for tissue protein purification, Western blotting, and imaging quantification have been described previously [17–20]. Membranes were incubated overnight at 4 °C with primary antibodies against SK3 and SK4 (IK-1) (Alomone Labs Ltd, Jerusalem, Israel). After washing with TBST, membranes were incubated with the appropriate secondary antibody conjugated to horseradish peroxidase. All membranes were also incubated with GAPDH (glyceraldehyde-3-phosphate) or alpha-tubulin (Cell Signaling, Beverly, MA) as loading controls.

Immunofluorescence microscopy for tissue section

The detailed methods have been described previously [17–20]. After being washed with PBS, tissue sections of atrial appendage were incubated overnight at 4 °C with anti-SK-3 and SK-4(IK) antibodies (Alomone Labs Ltd) and DAPI, and/or anti- smooth muscle α-actin antibody (Cell Signaling, Beverly, MA). The tissue sections were finally mounted with VECTASHIELD Mounting Medium with DAPI (4′,6-diamidino-2-phenylindole) (Vector Laboratories, Burlingame, CA).

Cell culture and immunofluorescent staining

Human coronary artery endothelial cells (HCAECs, passage 4) harvested from donors (patients) with and without diabetes (Lonza, Walkersville, MD) were cultured and grown in the EGMTM-2 Bullet Kit medium (Lonza) in a humidified incubator with 5% CO2 at 37 °C according to the manufacturer’s protocols and our previous work [20]. HCAECs were fixed by using paraformaldehyde (crossing-linking method) for immunofluorescent staining. After being washed with PBS, the fixed cells were incubated overnight at 4 °C, with anti-SK-2 antibody or anti-SK-4(IK) antibody (Alomone Labs Ltd). The cells were finally mounted with VECTASHIELD Mounting Medium with DAPI (4′,6-diamidino-2-phenylindole) (Vector Laboratories, Burlingame, CA).

Chemicals

Endothelin-1 and NS309 were purchased from Sigma-Aldrich (St. Louis, MO).

Data analysis

Data are expressed as the mean ± SD. A paired t test was performed for the data analysis of patient characteristics. For analysis of categorical data, Fisher’s exact test was employed. One-way ANOVA was employed for protein expression and other imaging. For the analysis of microvessel data, two-way repeated-measures ANOVA with a post hoc Bonferroni test were performed. P values less than 0.05 were considered significant. All statistical analysis was performed with GraphPad PRISM-6 Software (GraphPad Software, Inc, San Diego, CA).

Results

Patient characteristics

The characteristics of the 16 enrolled patients are shown in Table 1. All patients with pre-operative hypertension were treated with anti-hypertensive medications (β-blocker, calcium channel blocker, or angiotensin-converting enzyme inhibitor). The levels of pre-operative blood HgbA1c were 5.1 ± 0.3 in the ND patients, and 9.2 ± 0.4 in the DM patients (P = 0.0001).

Table 1.

Patient characteristics

Patient characteristics ND DM P values
Age (years)* 67 ± 8 70 ± 9 0.62
Male/Female (n) 5/3 6/2 1.00
HgbA1c (%)* 5.1 ± 0.3 9.2 ± 0.4 0.0001
Patient blood glucose (mg/dL, pre-CP/CPB)* 110 ± 14 216 ± 25 # 0.0001
Patient blood glucose (mg/dL, during CP/CPB)* 145 ± 14 188 ± 12 # 0.0006
Pre-operative insulin (n) 0 5# 0.47
Intra-operative insulin (n) 1 8# 0.001
Obesity (BMI > 30) 4 5 0.61
Hypercholesterolemia (n) 4 4 1.00
Hypertension (n) 7 8 0.3
Atrial fibrillation (n) 0 0 1.00
Duration of CPB (min)* 95 ± 16 102 ± 15 0.35
Cross-clamp time (min)* 81 ± 13 86 ± 12 0.41
CABG only (n) 5 5 1.00
CABG plus AVR or MVR 3 3 1.00
Oral antidiabetic medications 0 6# 0.002
Aspirin 6 7 0.52
Open in a new tab

HgbA1c hemoglobin A1c, CABG coronary artery bypass grafting, AVR aortic valve replacement, MVR mitral valve replacement, ND non-diabetics, DM diabetics

* Mean ± SD

# P < 0.05 vs. ND

Microvascular reactivity

The selective SK/IK inhibitor NS309 caused a dose-dependent relaxation response in both ND and DM microvessels (Fig. 1). At baseline (pre-CP/CPB), the relaxation response of coronary arterioles to the selective SK/IK inhibitor NS309 was significantly decreased in the DM group compared to the ND group (Fig. 1a, P < 0.05). The post-CP/CPB responses to NS309 were significantly diminished in both ND and DM groups (P < 0.05 vs. their pre-CPB, Fig. 1c, d), but the reduction was greater in the DM group than that of the ND group (P < 0.05, respectively, Fig. 1b).

Fig. 1.

Fig. 1

Open in a new tab

Dose-dependent relaxation response of coronary arterioles to the selective SK/IK activator NS309 in the setting of diabetes (DM) and cardioplegic arrest and cardiopulmonary bypass (CP/CPB). a Relaxation response to NS309 in diabetics and non-diabetic patients (ND) at baseline (Pre-CP/CPB); b relaxation response to NS309 Post-CP/CPB in ND and DM; c relaxation response of ND microvessels to NS309 between Pre- and Post-CP/CPB; d relaxation response of DM microvessels to NS309 between Pre- and Post-CP/CPB; Mean ± SD, n = 8/group. *P < 0.05 versus ND or Pre-CP/CPB;

Effect of CP/CPB on levels of SK-3 and SK-4(IK-1)

At baseline (pre-CP/CPB), there were no significant differences in the protein expression of total SK-3 (Fig. 2a, c) and SK-4(IK-1) (Fig. 2b, d) in the atrial myocardium between non-diabetic and diabetic patients (P > 0.05). There were no significant changes in SK-3 and SK-4(IK-1) post-CP/CPB compared with their pre-CP/CPB values (P < 0.05) and also no significant differences between ND and DM post-CPB (Fig. 2a–d).

Fig. 2.

Fig. 2

Open in a new tab

a, c Representative immunoblots of human atrial tissue samples harvested pre- and post-CP/CPB from diabetic (DM) and non-diabetic (ND) patients, Pre- pre-CP/CPB, Post- post-CP/CPB; b, d densitometric evaluation of immunoblot band intensity shows no significant differences in the levels of SK-3 (P = 0.08 vs. ND) and SK-4 (IK-1) (P = 0.3) polypeptides between ND and DM groups or between pre- and post-CP/CPB. Mean ± SD, n = 6/group

Vascular distribution of SK-3 and SK-4 (IK-1)

Immunofluorescent staining of SK-3 and SK-4 (IK-1) was observed in the coronary arteriolar endothelial cells (red, Fig. 3a, c) in atrial tissue slides. There were no significant differences in the immunofluorescent intensity of SK-3 and SK-4 (IK-1) at baseline (pre-CP/CPB) between ND and DM vessels (Fig. 3b, d). The pre-CP/CPB SK-3 and SK-4 (IK-1) were not significantly altered post-CP/CPB in both ND and DM groups (Fig. 3b, d). There were no significant differences in the post-CP/CPB SK-3 and SK-4 immunofluorescent intensity in vessels between ND and DM (P > 0.05).

Fig. 3.

Fig. 3

Open in a new tab

a, c Immunofluorescence staining of SK-3 and SK-4 (IK-1) in paraffin-embedded human atrial tissue samples from ND and DM patients in the setting of CP/CPB; Vessels were co-stained for smooth muscle α-actin (green), SK-3 or SK-4 (IK-1) red in endothelium; b, d densitometric analysis of signal intensities shows no significant differences in SK-3 and SK-4 (IK-1) distribution between the two groups or between pre- and post-CPB; c data are means ± SD, n = 6/group. (Color figure online)

Endothelial distribution of SK-2 and SK-4 (IK-1)

To further test if SK-2 and SK-4 (IK-1) are localized in the endothelium, we performed immunofluorescent staining of SK-2 and SK-4 (IK-1) in the cultured HCAECs. The signals of SK-2 (Red, Fig. 4a) and SK-4 (green, Fig. 4d) were strong in the HCAECs in both ND and DM groups. There were no significant differences in the fluorescent intensity of SK-2 and SK-4 of HCAECs between the ND and DM groups (Fig. 4b, c, e, f, P > 0.05).

Fig. 4.

Fig. 4

Open in a new tab

a, d Immunofluorescence staining of SK-2 and SK-4 (IK-1) in the cultured human coronary arterial endothelial cells (HCAECs) from ND and DM patients; Cells were co-stained for cell nuclei (blue), and SK-2 (red, a) or SK-4 (IK-1) (green, d); b, e Intensity of SK-2 (b) and SK-4 (IK-1, e); c, f Densitometric analysis of signal intensities shows no differences in SK-2 (c) and SK-4 (IK-1, f) distribution in HCAECs between ND and DM group Mean ± SD, n = 5/group. (Color figure online)

Discussion

The present study confirmed our previous findings that CP/CPB is associated with a decreased relaxation response of human coronary arterioles to the selective SK/IK activator NS309, suggesting that CP/CPB is associated the inactivation of endothelial SK/IK channels [17, 18]. Diabetes is associated with the reduction in endothelial SK/IK current density, endothelial hyperpolarization and SK/IK activator-induced endothelium-dependent coronary arteriolar relaxation in animals and humans [20]. Consistent with a previous study [20], we also observed that the dose-dependent relaxation response to the selective SK/IK activator NS309 was significantly decreased in the diabetic coronary arterioles compared to that of case-matched non-diabetics at baseline (pre-CP/CPB). These findings support the notion that diabetic inactivation of SK/IK contributes to coronary microvascular endothelial dysfunction. Importantly, the current study further demonstrates that diabetes, when combined with CP/CPB, further decreases the relaxation response of coronary arterioles to NS309. This novel finding suggests that diabetes is associated with further inhibition of SK/IK channels in the human coronary microvasculature early after CP/CPB and cardiac surgery. Thus, diabetic inhibition of SK/IK may also contribute to post-operative endothelial dysfunction in the diabetic patients early after CP/CPB and cardiac surgery.

Consistent with our previous study, we found that SK/IK channels are predominately present in the endothelial cells of human coronary microvessels and that CP/CPB did not change the total protein expression/localization of SK/IK in the non-diabetic patients [17, 18]. Diabetes-induced changes in endothelial SK/IK function and expression have been studied in detail in diabetic rodents [21–24]. For instance, decreased or increased mRNA/protein expression of endothelial SK/IK channels underlies the impaired EDHF-dilator response in the conduit artery of rodents [22–24]. In contrast, we recently observed that diabetes did not alter the expression/distribution of SK/IK polypeptides in the human myocardium or coronary microvessels at baseline (pre-CP/CPB) [20]. The current study confirms our previous findings by showing no changes in the total SK/IK protein expression/distribution in the diabetic heart and coronary vasculature at baseline. In addition, our study further indicates no alteration in SK/IK distribution in the diabetic HCAECs at baseline. To further examine if diabetes affects SK/IK protein expression/localization in the human myocardium and microvasculature in the setting of CP/CPB and cardiac surgery, we performed immunoblot and immunohistochemistry to quantify and localize SK/IK channel polypeptides. Notably, we found that diabetes did not affect SK/IK protein expression/distribution in the ischemic myocardium and coronary arterioles early after CP/CPB and cardiac surgery. The lack of diabetic changes in SK/IK protein levels in the setting CP/CPB suggests that the effect is post-translational.

There are still a number of limitations to the current study. For example, the precise mechanisms responsible for diabetic dys-regulation of SK/IK and endothelial function are still undefined in the current study. Interestingly, our previous work, along with others, have demonstrated that diabetes increases oxidative stress, NADPH oxidase (Nox) and PKC expression/activation in human myocardium, coronary microvessels and endothelial cells in the setting of CP/CPB [12, 13, 25, 26]. Nox and dysfunctional mitochondria mutually stimulate to enhance ROS production, and PKC expression/activation may play a pivotal role in endothelial dysfunction in diabetes and cardiac surgery [12, 13, 25–27]. The persistent overproduction/activation of NADH-Nox, mROS, and PKC in diabetes and cardiac surgery may negatively regulate SK/IK, endothelial function, and coronary arteriolar relaxation. Therefore, future work should focus on how metabolic changes from diabetes regulate SK/IK channels and coronary endothelial function in the setting of CP/CPB.

In conclusion, diabetes further inactivates SK/IK channels of coronary microvasculature early after CP/CPB and cardiac surgery. This alteration may contribute to post-operative endothelial dysfunction in diabetic patients after CP/CPB and cardiac surgery.

Acknowledgements

We would like to thank all of the nurses, physician assistants, and perfusionists in the cardiac surgery operating room, and Division of Cardiac Surgery, as well as Lifespan Hospitals for collecting patient consent forms, tissue samples, and the patient characteristics data.

Funding

This research project was supported by the National Institute of Health (NIH) 1R01HL127072-01A1, 1R01 HL136347-01, National Institute of General Medical Science (NIGMS) of the NIH [5P20-GM103652 (Pilot Project)] and AHA-Grant-in-Aid (#15GRNT25710105) to J.F. This work was supported in part by R01-HL46716 and RO1HL128831 to F.W.S.; and Summer Research-Early Identification Program (SR-EIP) of Leadership Alliance at Brown University (NIH-R25HL088992) to V.C.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Footnotes

Presented at the 12th Annual Academic Surgical Congress (ASC), Feb. 7–9, 2017, Las Vegas, NV.

References

  • 1.Ruel M, Khan TA, Voisine P, Bianchi C, Sellke FW. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg. 2004;26:1002–1014. doi: 10.1016/j.ejcts.2004.07.040. [DOI] [PubMed] [Google Scholar]
  • 2.Metais C, Li JY, Li J, Simons M, Sellke FW. Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression. Circulation. 1999;100:II-328–II-334. doi: 10.1161/01.CIR.100.suppl_2.II-328. [DOI] [PubMed] [Google Scholar]
  • 3.Metais C, Bianchi C, Li JY, Li J, Simons M, Sellke FW. Serotonin-induced human coronary microvascular contraction during acute myocardial ischemia is blocked by COX-2 inhibition. Basic Res Cardiol. 2001;96:59–67. doi: 10.1007/s003950170078. [DOI] [PubMed] [Google Scholar]
  • 4.Sodha NR, Feng J, Clements RT, et al. Protein kinase C-α modulates microvascular reactivity in the human coronary and skeletal microcirculation. Surgery. 2007;142:243–252. doi: 10.1016/j.surg.2007.03.010. [DOI] [PubMed] [Google Scholar]
  • 5.Robich MP, Chu LM, Feng J, Burgess TA, Laham RJ, Bianchi C, Sellke FW. Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium. J Thorac Cardiovasc Surg. 2010;140:1143–1152. doi: 10.1016/j.jtcvs.2010.06.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Feng J, Chu LM, Robich M, et al. Endothelin-1 induced contraction and signaling in the human skeletal muscle microcirculation. Circulation. 2010;122:S150–S155. doi: 10.1161/CIRCULATIONAHA.109.928226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Feng J, Liu YH, Khabbaz KR, Hagberg R, Osipov RM, Sodha NR, Sellke FW. Endothelin-1 induced contractile responses of human coronary arterioles via endothelin-A receptors and PKC-α signaling pathways. Surgery. 2010;147:798–804. doi: 10.1016/j.surg.2009.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Feng J, Liu YH, Chu LM, et al. Thromboxane induced contractile response of human coronary arterioles is diminished post-cardioplegic arrest. Ann Thorac Surg. 2011;92:829–836. doi: 10.1016/j.athoracsur.2011.04.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Feng J, Liu YH, Singh AK, et al. Impaired contractile response of human peripheral arterioles to thromboxane A-2 after cardiopulmonary bypass. Surgery. 2011;150:263–271. doi: 10.1016/j.surg.2011.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Feng J, Liu YH, Khabbaz K, et al. Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients. Surgery. 2011;149:247–252. doi: 10.1016/j.surg.2010.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Verma S, Maitland A, Weisel RD, et al. Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. J Thorac Cardiovasc Surg. 2002;123:1114–1119. doi: 10.1067/mtc.2002.121972. [DOI] [PubMed] [Google Scholar]
  • 12.Feng J, Liu YH, Chu LM, et al. Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes. Circulation. 2012;126:S73–S80. doi: 10.1161/CIRCULATIONAHA.111.084590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Feng J, Chu LM, Dobrilovic N, Liu YH, Singh AK, Sellke FW. Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus. Surgery. 2012;152:282–289. doi: 10.1016/j.surg.2012.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Feng J, Liu Y, Sabe AA, Sadek AA, Singh AK, Sodha NR, Sellke FW. Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients. Eur J Cardiothorac Surg. 2016;49:937–943. doi: 10.1093/ejcts/ezv202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Feng J, Liu Y, Singh AK, Ehsan A, Sellke N, Liang J, Sellke FW. Effects of diabetes and cardiopulmonary bypass on adherens-junction-protein expression of human peripheral tissue. Surgery. 2017;161(3):823–829. doi: 10.1016/j.surg.2016.08.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Feng J, Liu YH, Dobrilovic N, et al. Altered apoptosis-related signaling after cardioplegic arrest in patients with uncontrolled type 2 diabetes. Circulation. 2013;128:S144–S151. doi: 10.1161/CIRCULATIONAHA.112.000332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Feng J, Liu YH, Clements RT, et al. Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegia arrest. Circulation. 2008;118(Suppl I):S46–S51. doi: 10.1161/CIRCULATIONAHA.107.755827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liu YH, Sellke EW, Feng J, et al. Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypass. Surgery. 2008;144:239–244. doi: 10.1016/j.surg.2008.03.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Feng J, Liu YH, Khabbaz KR, et al. Large conductance calcium-activated potassium channels contribute to the reduced myogenic tone of peripheral microvasculature after cardiopulmonary bypass. J Surg Res. 2009;157:123–128. doi: 10.1016/j.jss.2009.03.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu YH, Xie A, Singh AK, Ehsan A, Choudhary G, Dudley S, Sellke FW, Feng J. Inactivation of endothelial SKCa/IKCa contributes to coronary arteriolar dysfunction in diabetic patients. JAHA. 2015;4(8):e002062. doi: 10.1161/JAHA.115.002062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11:61–74. doi: 10.1007/s11154-010-9134-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Burnham MP, Johnson IT, Weston AH. Impaired small-conductance Ca2+-activated K + channel-dependent EDHF responses in type II diabetic ZDF rats. Br J Pharmacol. 2006;148:434–441. doi: 10.1038/sj.bjp.0706748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Weston AH, Absi M, Harno E, et al. The expression and function of Ca(2+)-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes. Br J Pharmacol. 2008;154:652–662. doi: 10.1038/bjp.2008.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol. 2005;146:1110–1118. doi: 10.1038/sj.bjp.0706417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Feng J, Anderson K, Mitchell H, Singh AK, Ehsan A, Liu Y, Sellke FW. Diabetic upregulation of COX-2 contributes to altered coronary reactivity after cardiac surgery. Ann Thorac Surg. 2017;104(2):568–576. doi: 10.1016/j.athoracsur.2016.11.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Shenouda SM, Widlansky ME, Chen K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124:444–453. doi: 10.1161/CIRCULATIONAHA.110.014506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49(11):1939–1945. doi: 10.2337/diabetes.49.11.1939. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biochemistry are provided here courtesy of Springer

RESOURCES